Correction to: Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma

Detalles Bibliográficos
Autores principales: Powles, Thomas, Choueiri, Toni K., Motzer, Robert J., Jonasch, Eric, Pal, Sumanta, Tannir, Nizar M., Signoretti, Sabina, Kaldate, Rajesh, Scheffold, Christian, Wang, Evelyn, Aftab, Dana T., Escudier, Bernard, George, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442414/
https://www.ncbi.nlm.nih.gov/pubmed/34525968
http://dx.doi.org/10.1186/s12885-021-08693-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442414/
https://www.ncbi.nlm.nih.gov/pubmed/34525968
http://dx.doi.org/10.1186/s12885-021-08693-9

Ejemplares similares